Potentially life-threatening cardiac dysrhythmia in a child with selenium deficiency and phenylketonuria

L G Greeves1, D J Carson, B G Craig

  • 1Department of Child Health and Medicine, Royal Belfast Hospital for Sick Children, Queen's University, Belfast, N. Ireland.

Insights

Children with phenylketonuria (PKU) on dietary treatment often have selenium deficiency. This case highlights episodic ventricular tachycardia in an infant with PKU, linked to low selenium levels.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Cardiology

Background:

  • Phenylketonuria (PKU) requires strict dietary management, often leading to nutrient deficiencies.
  • Selenium (Se) is an essential trace element crucial for antioxidant defense and overall health.
  • Glutathione peroxidase (GSHPX) is a key selenoenzyme involved in protecting cells from oxidative damage.

Observation:

  • A 9-month-old infant with PKU presented with episodic ventricular tachycardia.
  • The infant exhibited significantly low serum selenium (Se) levels (0.13 mumol/l) and low whole blood glutathione peroxidase (GSHPX) activity (16 U/g Hb).
  • These biochemical markers indicated a state of selenium deficiency.

Findings:

  • A direct correlation was observed between PKU dietary management, selenium deficiency, and cardiac dysrhythmia.
  • The infant's low Se and GSHPX levels suggest impaired antioxidant capacity, potentially contributing to cardiac issues.
  • Ventricular tachycardia in this context points to a possible novel complication of PKU treatment.

Implications:

  • Routine cardiac auscultation is advised for young children with PKU during follow-up.
  • Selenium deficiency should be considered as a potential etiological factor in cardiac dysrhythmias in PKU patients.
  • Prompt Se supplementation may be necessary to correct deficiency and manage associated cardiac complications.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...